These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32401306)

  • 1. Development of novel anti-malarial from structurally diverse library of molecules, targeting plant-like CDPK1, a multistage growth regulator of P. falciparum.
    Jain R; Gupta S; Munde M; Pati S; Singh S
    Biochem J; 2020 May; 477(10):1951-1970. PubMed ID: 32401306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The motor complex of Plasmodium falciparum: phosphorylation by a calcium-dependent protein kinase.
    Green JL; Rees-Channer RR; Howell SA; Martin SR; Knuepfer E; Taylor HM; Grainger M; Holder AA
    J Biol Chem; 2008 Nov; 283(45):30980-9. PubMed ID: 18768477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular dynamics simulations and biochemical characterization of Pf14-3-3 and PfCDPK1 interaction towards its role in growth of human malaria parasite.
    Jain R; Dey P; Gupta S; Pati S; Bhattacherjee A; Munde M; Singh S
    Biochem J; 2020 Jun; 477(12):2153-2177. PubMed ID: 32484216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical Screening of Five Protein Kinases from Plasmodium falciparum against 14,000 Cell-Active Compounds.
    Crowther GJ; Hillesland HK; Keyloun KR; Reid MC; Lafuente-Monasterio MJ; Ghidelli-Disse S; Leonard SE; He P; Jones JC; Krahn MM; Mo JS; Dasari KS; Fox AM; Boesche M; El Bakkouri M; Rivas KL; Leroy D; Hui R; Drewes G; Maly DJ; Van Voorhis WC; Ojo KK
    PLoS One; 2016; 11(3):e0149996. PubMed ID: 26934697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imidazopyridazine Inhibitors of Plasmodium falciparum Calcium-Dependent Protein Kinase 1 Also Target Cyclic GMP-Dependent Protein Kinase and Heat Shock Protein 90 To Kill the Parasite at Different Stages of Intracellular Development.
    Green JL; Moon RW; Whalley D; Bowyer PW; Wallace C; Rochani A; Nageshan RK; Howell SA; Grainger M; Jones HM; Ansell KH; Chapman TM; Taylor DL; Osborne SA; Baker DA; Tatu U; Holder AA
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1464-75. PubMed ID: 26711771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced Activity of Mutant Calcium-Dependent Protein Kinase 1 Is Compensated in Plasmodium falciparum through the Action of Protein Kinase G.
    Bansal A; Ojo KK; Mu J; Maly DJ; Van Voorhis WC; Miller LH
    mBio; 2016 Dec; 7(6):. PubMed ID: 27923926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PfCDPK1 mediated signaling in erythrocytic stages of Plasmodium falciparum.
    Kumar S; Kumar M; Ekka R; Dvorin JD; Paul AS; Madugundu AK; Gilberger T; Gowda H; Duraisingh MT; Keshava Prasad TS; Sharma P
    Nat Commun; 2017 Jul; 8(1):63. PubMed ID: 28680058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and antiparasitic properties of inhibitors of the Plasmodium falciparum calcium-dependent protein kinase PfCDPK1.
    Ansell KH; Jones HM; Whalley D; Hearn A; Taylor DL; Patin EC; Chapman TM; Osborne SA; Wallace C; Birchall K; Large J; Bouloc N; Smiljanic-Hurley E; Clough B; Moon RW; Green JL; Holder AA
    Antimicrob Agents Chemother; 2014 Oct; 58(10):6032-43. PubMed ID: 25070106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transport proteins as drug targets in Plasmodium falciparum. New perspectives in the treatment of malaria].
    Ellekvist P; Colding H
    Ugeskr Laeger; 2006 Mar; 168(13):1314-7. PubMed ID: 16579884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening the Medicines for Malaria Venture Pathogen Box for invasion and egress inhibitors of the blood stage of Plasmodium falciparum reveals several inhibitory compounds.
    Dans MG; Weiss GE; Wilson DW; Sleebs BE; Crabb BS; de Koning-Ward TF; Gilson PR
    Int J Parasitol; 2020 Mar; 50(3):235-252. PubMed ID: 32135179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening and In Vitro Evaluation of Potential Plasmodium falciparum Leucyl Aminopeptidase Inhibitors.
    Chaudhary M; Singh V; Anvikar AR; Sahi S
    Curr Comput Aided Drug Des; 2016; 12(4):282-293. PubMed ID: 27449897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3,5-bis(benzylidene)-4-piperidones and related N-acyl analogs: a novel cluster of antimalarials targeting the liver stage of Plasmodium falciparum.
    Das U; Singh RS; Alcorn J; Hickman MR; Sciotti RJ; Leed SE; Lee PJ; Roncal N; Dimmock JR
    Bioorg Med Chem; 2013 Dec; 21(23):7250-6. PubMed ID: 24139941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Plasmodium falciparum CDPK1 by conditional expression of its J-domain demonstrates a key role in schizont development.
    Azevedo MF; Sanders PR; Krejany E; Nie CQ; Fu P; Bach LA; Wunderlich G; Crabb BS; Gilson PR
    Biochem J; 2013 Jun; 452(3):433-41. PubMed ID: 23548171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification via a Parallel Hit Progression Strategy of Improved Small Molecule Inhibitors of the Malaria Purine Uptake Transporter that Inhibit
    Sosa Y; Deniskin R; Frame IJ; Steiginga MS; Bandyopadhyay D; Graybill TL; Kallal LA; Ouellette MT; Pope AJ; Widdowson KL; Young RJ; Akabas MH
    ACS Infect Dis; 2019 Oct; 5(10):1738-1753. PubMed ID: 31373203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor for Activated C-Kinase 1 (PfRACK1) is required for Plasmodium falciparum intra-erythrocytic proliferation.
    Blomqvist K; DiPetrillo C; Streva VA; Pine S; Dvorin JD
    Mol Biochem Parasitol; 2017 Jan; 211():62-66. PubMed ID: 27732881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of the antiplasmodial activity of Hsp90 inhibitors.
    Murillo-Solano C; Dong C; Sanchez CG; Pizarro JC
    Malar J; 2017 Jul; 16(1):292. PubMed ID: 28724415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treatment of Plasmodium falciparum-infected erythrocytes with chloroquine leads to accumulation of ferriprotoporphyrin IX bound to particular parasite proteins and to the inhibition of the parasite's 6-phosphogluconate dehydrogenase.
    Famin O; Ginsburg H
    Parasite; 2003 Mar; 10(1):39-50. PubMed ID: 12669348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-Hexadecynoic acid inhibits plasmodial FAS-II enzymes and arrests erythrocytic and liver stage Plasmodium infections.
    Tasdemir D; Sanabria D; Lauinger IL; Tarun A; Herman R; Perozzo R; Zloh M; Kappe SH; Brun R; Carballeira NM
    Bioorg Med Chem; 2010 Nov; 18(21):7475-85. PubMed ID: 20855214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Antimalarial Compounds That Require CLAG3 for Their Uptake by
    Mira-Martínez S; Pickford AK; Rovira-Graells N; Guetens P; Tintó-Font E; Cortés A; Rosanas-Urgell A
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30782998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression signatures and small-molecule compounds link a protein kinase to Plasmodium falciparum motility.
    Kato N; Sakata T; Breton G; Le Roch KG; Nagle A; Andersen C; Bursulaya B; Henson K; Johnson J; Kumar KA; Marr F; Mason D; McNamara C; Plouffe D; Ramachandran V; Spooner M; Tuntland T; Zhou Y; Peters EC; Chatterjee A; Schultz PG; Ward GE; Gray N; Harper J; Winzeler EA
    Nat Chem Biol; 2008 Jun; 4(6):347-56. PubMed ID: 18454143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.